Close Menu

NEW YORK (GenomeWeb) – GenMark Diagnostics announced today that it has submitted 510(k) applications to the US Food and Drug Administration for its ePlex sample-to-answer instrument and respiratory pathogen panel.

ePlex combines digital microfluidics with the firm's eSensor electrochemical detection technology to enable precise fluid management and accurate results, and the respiratory panel detects clinically relevant viral and bacterial targets from nasopharyngeal samples, the firm said.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sep
30
Sponsored by
LGC SeraCare Life Sciences

Non-invasive prenatal testing (NIPT) continues to expand globally to support maternal-fetal patient care. 

Oct
09
Sponsored by
PerkinElmer

As cases of COVID-19 continued to grow this spring and summer in the US, so too did the number of Emergency Use Authorizations from the FDA for clinical diagnostic tests aimed at detecting current and past infections.